Katie Barrall serves as the Director of Vaccine Commercial Development at Pfizer, leading global commercial development for select assets since September 2021. Prior experience at Pfizer includes roles as Senior Manager of mRNA Commercial Strategy & Innovation and Manager in the Marketing Rotational Program, where involvement spanned key teams relating to mRNA global commercial development. Katie's previous experience also encompasses an MBA Summer Associate position focusing on the hemophilia portfolio in U.S. marketing and consulting roles at Semler Brossy Consulting Group, FW Cook, and ZS. Educational credentials include an MBA from Columbia Business School and a Bachelor of Arts in Economics-Mathematics and Art History from Columbia University.
This person is not in any teams
This person is not in any offices